XPONANCE, INC. - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 212 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
XPONANCE, INC. ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$23,344
-29.3%
26,348
+24.1%
0.00%
-100.0%
Q3 2022$33,000
-19.5%
21,233
+4.7%
0.00%0.0%
Q2 2022$41,000
+24.2%
20,288
+42.9%
0.00%0.0%
Q1 2022$33,000
-49.2%
14,200
+0.8%
0.00%0.0%
Q4 2021$65,000
-35.0%
14,083
+7.8%
0.00%
-50.0%
Q3 2021$100,000
-31.0%
13,068
-12.4%
0.00%
-33.3%
Q2 2021$145,00014,9250.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,799,790$11,059,0003.50%
Intellectus Partners, LLC 1,095,840$4,329,0002.20%
Cormorant Asset Management, LP 1,690,800$6,679,0000.97%
Avoro Capital Advisors LLC 1,192,130$4,709,0000.60%
Vident Investment Advisory, LLC 170,534$674,0000.07%
GAGNON SECURITIES LLC 11,116$44,0000.02%
MATRIX ASSET ADVISORS INC/NY 22,000$87,0000.02%
R&F Capital Advisors LP 12,878$51,0000.01%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 96,154$380,0000.01%
Virtu KCG Holdings LLC 27,425$108,0000.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders